MDCK Suspension Platform
Source: Sartorius

The MDCK Suspension Cell Line from Sartorius is derived from the ATCC MDCK (NBL-2) CCL-34™ cell line. This cell line has been directly adapted to the Sartorius 4Cell® MDXK CD medium, which is a chemically defined medium free from animal-derived components. Importantly, this adaptation process has been carried out without any genetic modifications, ensuring the cell line remains true to its original characteristics. This monoclonal cell line boasts an extensive and well-documented history, making it a reliable and trusted choice for various research and bioproduction applications.
Access the full datasheet to learn more.
access the Datasheet!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Sartorius
This website uses cookies to ensure you get the best experience on our website. Learn more